Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring

NCT04099628 is registered in ClinicalTrials.gov with Institut de Recherche pour le Developpement as lead sponsor.

NCT NCT04099628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04099628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring
Lead sponsor
Institut de Recherche pour le Developpement
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2019
Completion date
January 31, 2021
Enrollment
13,747 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

african trypanosomiases, human african trypanosomiasis, sleeping sickness, trypanosoma brucei gambiense; infection, trypanosomiasis; african, due to trypanosoma brucei gambiense, gambiense, west african sleeping sickness